Skip to main content

Physician Search

 


Displaying 61 - 70 of 280

A multicenter Phase II trial of Paclitaxel with and without Nivolumab in Taxane nave, and Nivolumab and Cabozantinib in Taxane pretreated subjects with angiosarcoma.

Sarcoma

Sarcoma
II
Davis, Elizabeth
NCT04339738
NRGSARA091902

Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)

Multiple Cancer Types

Pediatrics, Wilms / Other Kidney (Pediatrics)
II
Benedetti, Daniel
NCT04322318
COGAREN1921


PVSRIPO with and without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma.

Melanoma

Melanoma
II
Johnson, Douglas
NCT04577807
VICCMEL20109

A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y90 TARE in Patients with Unresectable Hepatocellular Carcinoma

Liver

Liver
II
Goff, Laura
NCT04541173
VICCGI20110


A Phase 2 Study of Blinatumomab (NSC# 765986, IND# 125462) in Combination with Nivolumab (NSC# 748726, IND# 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/=1 to <31 Years Old with First Relapse

Multiple Cancer Types

Pediatric Leukemia, Pediatrics
II
Zarnegar-Lumley, Sara
NCT04546399
COGAALL1821

A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Nave Metastatic Anal Cancer Patients

Rectal

Rectal
III
Eng, Cathy
NCT04444921
ECOGGIEA2176

A PHASE 1/2 DOSE ESCALATION AND DOSE EXPANSION STUDY OF MECBOTAMAB VEDOTIN (BA3011) ALONE AND IN COMBINATION WITH NIVOLUMAB IN ADULT AND ADOLESCENT PATIENTS 12 YEARS AND OLDER WITH ADVANCED SOLID TUMORS

Multiple Cancer Types

Miscellaneous, Pediatric Solid Tumors, Pediatrics, Sarcoma
I/II
Davis, Elizabeth
NCT03425279
VICCSAR20117